Life Sciences

R&D

Scope for action: How the life sciences industry can make pr...

With the next global climate conference, COP28 in Dubai, having begun on 30th November, many businesses have been taking stock of their own record.

R&D

Investing in the gleams of positivity and hope for life scie...

In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at Brit

Patients

The rapidly evolving role of patient organisations

Ben Hargreaves finds that patient organisations are providing an increasingly essential role as a linker between patients and the rest of the life sciences industry.

Digital

An investor’s perspective on bio and tech

Increasingly, the life sciences world is characterised by the collision of the worlds of technology and biology.

Sales & Marketing

Veeva Commercial Summit '23: The power of connectivity

Veeva Systems’ Commercial Summit returned to Madrid for 2023, with over 1,500 life sciences industry professionals in attendance.

News

UK's Autumn Budget welcomed by pharma trade organisations

The life sciences industry in the UK has responded positively to measures introduced in the Autumn Budget detailed today by Chancellor Jeremy Hunt, including confirmation